Allergy Thera. Regulatory News (AGY)

2 Nov 2006 11:39

Allergy Therapeutics PLC02 November 2006 1 November 2006 Allergy Therapeutics plc Grant of Options Allergy Therapeutics plc (the "Company") announces that on 9 October 2006,provisional shares of 0.1 pence each in the share capital of the Company wereawarded to Keith Carter (Chief Executive Officer), Ian Postlethwaite (FinanceDirector), Christian Gratz (Executive Director) and Tom Holdich (ExecutiveDirector) at nil cost, pursuant to the Allergy Therapeutics plc 2005 Long TermShare Incentive Plan (the "LTIP"), as follows: Director Number of Date from which Expiry date Total provisional provisional shares exercisable shares held under awarded LTIPKeith Carter 142,500 9th October 2009 9th October 2016 342,500Ian Postlethwaite 95,000 9th October 2009 9th October 2016 225,000Christian Gratz 95,000 9th October 2009 9th October 2016 225,000Tom Holdich 95,000 9th October 2009 9th October 2016 225,000 Distribution of ordinary shares of 0.1 pence each under the LTIP is conditionalon the Company's performance over the course of the next three financial years. This information is provided by RNS The company news service from the London Stock Exchange